References
Shi Z, Tiwari AK, Shukla S, Robey RW, Singh S, Kim IW, Bates SE, Peng X, Abraham I, Ambudkar SV, Talele TT, Fu LW, Chen ZS (2011) Sildenafil reverses ABCB1—and ABCG2-mediated chemotherapeutic drug resistance. Cancer Res 71(8):3029–3041
Magro L, Moretti U, Leone R (2012) Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions. Expert Opin Drug Saf 11:83–94
Van Roon EN, Flikweert S, Le Comte M, Langendijk PNJ, Kwee-Zuiderwijk WJM, Smits P, Brouwers JRBJ (2005) Clinical relevance of drug-drug interactions: a structured assessment procedure. Drug Saf 28:1131–1139
Pejčić AV, Janković SM, Davidović G (2018) Drug–drug interactions in patients with acute coronary syndrome across phases of treatment. Intern Emerg Med. https://doi.org/10.1007/s11739-018-1994-8
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that she has no conflict of interest.
Statement of human and animal rights
The article does not contain any study on human participants or animals.
Informed consent
Informed consent was not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cecchi, E. Drug–drug interaction knowledge to save the patient from iatrogenic disease and to improve the diagnostic process. Intern Emerg Med 14, 345–347 (2019). https://doi.org/10.1007/s11739-018-02016-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-018-02016-w